The global fluorescent immunoassay market is experiencing steady expansion, driven by the increasing demand for advanced diagnostic technologies and the rising prevalence of infectious and chronic diseases. The market is projected to grow from US$ 2.81 billion in 2023 to US$ 4.51 billion by 2031, registering a CAGR of 5.8% during the forecast period (2023–2031). This growth is...